- AU$17.92m
- AU$21.25m
- AU$16.47m
- 10
- 57
- 29
- 21
Annual income statement for Dxn, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.23 | 15.2 | 7.75 | 11.3 | 16.5 |
| Cost of Revenue | |||||
| Gross Profit | 2.45 | 4.75 | 4.91 | 6.35 | 5.84 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13 | 22.2 | 17.4 | 13.6 | 18.6 |
| Operating Profit | -4.81 | -7.01 | -9.61 | -2.3 | -2.11 |
| Net Income Before Taxes | -4.81 | -7.01 | -9.61 | -2.3 | -2.11 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.81 | -7.01 | -9.61 | -2.3 | -2.31 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4.81 | -6.9 | -9.61 | -2.3 | -2.31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.81 | -6.9 | -9.61 | -2.3 | -2.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.112 | -0.076 | -0.049 | -0.015 | -0.009 |